Recombinant HSA Purification via Multi-Step Chromatography
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing recombinant human serum albumin (HSA) face challenges such as insufficient plasma supply, high production costs, and risks associated with infectious pathogens, while existing expression systems like E. coli and animal cells have low expression levels and high costs, making them unsuitable for industrial production.
Innovation Solution
A chromatography method involving cation exchange, anion exchange, and hydrophobic interaction chromatography steps using specific resins like Capto-MMC, Capto-Adhere, and Phenyl Sepharose to purify recombinant HSA from transgenic rice seeds, achieving a purity of 99.9999% and effectively removing endotoxins.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If plasma extraction method is used to produce HSA, then clinical availability is improved, but source insufficiency and infectious pathogen risks worsen
Solution Approach 1:
The patent extracts the harmful element (infectious pathogens) from the production system by replacing plasma-based extraction with recombinant DNA technology in rice plants. The HSA protein is produced through genetic engineering rather than plasma extraction, eliminating pathogen risks while maintaining clinical availability.
Solution Approach 2:
The patent introduces rice plants as an intermediary production system. Instead of directly extracting HSA from human plasma, the HSA gene is inserted into rice plants which then serve as bio-factories to produce the protein, acting as a safe intermediary that eliminates infectious pathogen transmission while providing sufficient production capacity.
2Productivity
If E. coli or animal cell expression systems are used, then production capacity is improved, but production cost and complexity worsen
Solution Approach 1:
The patent employs rice plants as a disposable, renewable production system. Rather than maintaining complex animal cell culture infrastructure, the system uses agricultural cultivation which is simpler, more scalable, and eliminates the need for expensive bioreactors and sterile maintenance protocols associated with animal cell systems.
3Device complexity
If traditional chromatography methods are used for purification, then process simplicity is improved, but purification precision and endotoxin removal worsen
Solution Approach 1:
The patent segments the purification process into three distinct chromatography steps: cation exchange chromatography for initial purification, anion exchange chromatography for intermediate purification, and hydrophobic interaction chromatography for final polishing. Each step targets specific impurities and progressively increases purity to achieve 99.9999% HSA with endotoxin removal.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method ensures high-purity recombinant HSA production with efficient endotoxin removal, addressing the limitations of traditional methods by providing a scalable and safer alternative for clinical use.
Implementation Method 1
subjecting crude extract of recombinant human serum albumin to cation exchange chromatography
Implementation Method 2
subjecting the primary product I to anion exchange chromatography
Implementation Method 3
subjecting the secondary product II to hydrophobic interaction chromatography, to obtain the target product, high-purity recombinant human serum albumin
Data Source
AI summary
Disclosed is a chromatographic method for isolating and purifying high-purity recombined human serum albumin, comprising: conducting cation-exchange chromatography on recombined human serum albumin, and adding alcohol to a buffer solution to remove endotoxin, so as to obtain a primary product I; under binding conditions, conducting anion/hydrophobic composite resin exchange chromatography on the primary product I to obtain an intermediate product II; conducting hydrophobic chromatography on the intermediate product II to obtain the target product, the purified high-purity recombined human serum albumin. The purity of the recombined human serum albumin obtained by isolating and purifying with the chromatographic method of the present invention is greater than 99.9999%, and the content of the endotoxin meets the criteria stipulated by Chinese pharmacopoeia.